z-logo
open-access-imgOpen Access
Future perspectives in diabesity treatment: Semaglutide, a glucagon‑like peptide 1 receptor agonist (Review)
Author(s) -
Mariana Tilincă,
Robert Aurelian Tiucă,
Cristiiculas,
Andreea Varga,
Ioan Ţilea
Publication year - 2021
Publication title -
experimental and therapeutic medicine
Language(s) - English
Resource type - Journals
eISSN - 1792-1015
pISSN - 1792-0981
DOI - 10.3892/etm.2021.10601
Subject(s) - semaglutide , medicine , exenatide , glucagon receptor , glucagon like peptide 1 receptor , gastric emptying , pharmacology , diabetes mellitus , type 2 diabetes , liraglutide , glucagon like peptide 1 , endocrinology , glucagon , insulin , agonist , receptor , stomach

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here